Lee Mi Jung, Shin Dong Ho, Ko Kwang Il, Koo Hyang Mo, Kim Chan Ho, Doh Fa Mee, Oh Hyung Jung, Han Seung Hyeok, Yoo Tae-Hyun, Kim Beom Seok, Kang Shin-Wook, Choi Kyu Hun
Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Republic of Korea.
Growth Horm IGF Res. 2013 Oct;23(5):170-4. doi: 10.1016/j.ghir.2013.06.004. Epub 2013 Jul 11.
The insulin-like growth factor (IGF) system is known to be associated with inflammation in various populations. However, the association between the IGF system and inflammation has not previously been investigated in automated peritoneal dialysis (APD) patients. Therefore, the aim of this study was to investigate whether the IGF system correlates with inflammation in APD patients.
We prospectively determined IGF-I activity, the ratio of serum IGF-I concentrations to those of IGF binding protein-3 (IGFBP-3), and inflammatory markers at initiation of APD and after 6 months of follow-up in 21 incident APD patients.
The mean age was 55.2 ± 13.1 years, and 11 patients (52.3%) were male. Continuous cyclic PD (CCPD) was performed in 11 patients, and nocturnal intermittent PD (NIPD) in 10 patients. The mean value of IGF-I/IGFBP-3 was 0.21 ± 0.13. At baseline, IGF-I/IGFBP-3 was negatively correlated with high-sensitivity C-reactive protein (hs-CRP) (r = -0.27, P = 0.032) and interleukin-6 (IL-6) (r = -0.19, P = 0.046) concentrations. After 6 months, IGF-I/IGFBP-3 (P = 0.048) had decreased significantly, while the hs-CRP (P = 0.036) increased significantly in the CCPD group. However, there were no significant changes in IGF-I/IGFBP-3 (P = 0.59) and hs-CRP (P = 0.14) during 6 months in the NIPD group. Furthermore, compared with the NIPD group, IGF-I/IGFBP-3 (P = 0.041) decreased greater, whereas hs-CRP (P = 0.048) concentrations increased greater in the CCPD group.
The IGF system was significantly associated with inflammatory markers in incident APD patients, and different APD modalities modulate the IGF system and inflammation.
胰岛素样生长因子(IGF)系统已知与不同人群的炎症相关。然而,此前尚未在自动化腹膜透析(APD)患者中研究IGF系统与炎症之间的关联。因此,本研究的目的是调查IGF系统与APD患者炎症之间是否存在相关性。
我们前瞻性地测定了21例新发APD患者开始腹膜透析时及随访6个月后的IGF-I活性、血清IGF-I浓度与IGF结合蛋白-3(IGFBP-3)浓度的比值以及炎症标志物。
平均年龄为55.2±13.1岁,11例患者(52.3%)为男性。11例患者进行持续循环腹膜透析(CCPD),10例患者进行夜间间歇性腹膜透析(NIPD)。IGF-I/IGFBP-3的平均值为0.21±0.13。在基线时,IGF-I/IGFBP-3与高敏C反应蛋白(hs-CRP)(r = -0.27,P = 0.032)和白细胞介素-6(IL-6)(r = -0.19,P = 0.046)浓度呈负相关。6个月后,CCPD组中IGF-I/IGFBP-3(P = 0.048)显著下降,而hs-CRP(P = 0.036)显著升高。然而,NIPD组在6个月期间IGF-I/IGFBP-3(P = 0.59)和hs-CRP(P = 0.14)无显著变化。此外,与NIPD组相比,CCPD组中IGF-I/IGFBP-3(P = 0.041)下降幅度更大,而hs-CRP(P = 0.048)浓度升高幅度更大。
IGF系统与新发APD患者的炎症标志物显著相关,不同的APD模式可调节IGF系统和炎症。